Puma Biotechnology | Umsatzkosten



Cost Of Sales Veränderung Datum
Agios Pharmaceuticals USD 1.7M 617K 2025-06
Alnylam Pharmaceuticals USD 142.95M 71.91M 2025-06
Amgen USD 2.6B 507M 2025-03
Biogen USD 605M 24.3M 2025-06
BioMarin Pharmaceutical USD 154.94M 3.38M 2025-06
Daiichi Sankyo JPY 92.35B 1.99B 2025-06
Exelixis USD 19.47M 298K 2025-07
Gilead Sciences USD 1.5B 39M 2025-06
Glaxosmithkline GBP 2.52B 199M 2024-12
Incyte USD 78.77M 10.96M 2025-06
MacroGenics USD 5.49M 3.62M 2024-12
Moderna USD 119M 29M 2025-06
Novartis USD 3.32B 95M 2025-06
Pfizer USD 4.99B 2.4B 2025-06
PTC Therapeutics USD 15.48M 2.62M 2025-06
Regeneron Pharmaceuticals USD 530.2M 264.7M 2025-06
Roche Holding CHF 4.13B 393.5M 2024-12
Sarepta Therapeutics USD 153.22M 15.66M 2025-06
Takeda JPY 384.68B 2.6B 2025-06
TG Therapeutics USD 18.94M 3.4M 2025-06
Ultragenyx Pharmaceutical USD 28.66M 11.77M 2025-03
Vertex Pharmaceuticals USD 407.5M 44.5M 2025-06


Puma Biotechnology Umsatzkosten - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.